Pharmaceutical composition used for treating thromboembolic disorders, comprises rivaroxaban, mannitol, anhydrous citric acid, hypromellose, sodium benzoate, combination of xanthan gum and mixture of microcrystalline cellulose and carboxymethylcellulose sodium, sucralose, flavoring agent, excipients
2023-10-04
专利权人ALKEM LAB LTD (ALKE-Non-standard)
申请日期2023-10-04
专利号IN202321066401-A
成果简介NOVELTY - Pharmaceutical composition comprises: (a) 0.5-10 wt.% rivaroxaban or its salt; (b) 50-80 wt.% mannitol; (c) 1-5 wt.% anhydrous citric acid; (d) 0.5-3 wt.% hypromellose; (e) 1-8 wt.% sodium benzoate; (f) 10-30 wt.% combination of xanthan gum, and mixture of microcrystalline cellulose and carboxymethylcellulose sodium; (g) 0.5-3 wt.% sucralose; (h) 0.5-3 wt.% flavoring agent; and optionally other its excipients. USE - Pharmaceutical composition used for treating thromboembolic disorder, or venous thromboembolism (VTE); and reducing risk of recurrent VTE in pediatric patients from birth to less than 18 years and for thromboprophylaxis in pediatric patients 2 years and older with congenital heart disease after the Fontan procedure. Test details are described but no results given. ADVANTAGE - The pharmaceutical composition has improved stability, and easy to swallow to children. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a method of preparing a pharmaceutical composition, which involves: using wet granulation process.
IPC 分类号A61J-003/07 ; A61K-031/5377 ; A61K-009/51
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20130
专题中国科学院新疆生态与地理研究所
作者单位
ALKEM LAB LTD (ALKE-Non-standard)
推荐引用方式
GB/T 7714
SINGH S,SHIROLE Y,WAGH K,et al. Pharmaceutical composition used for treating thromboembolic disorders, comprises rivaroxaban, mannitol, anhydrous citric acid, hypromellose, sodium benzoate, combination of xanthan gum and mixture of microcrystalline cellulose and carboxymethylcellulose sodium, sucralose, flavoring agent, excipients. IN202321066401-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。